Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus

Transplantation

Volumn 77, Issue 7, 2004, Pages 1066-1070

  Bozorgzadeh, Adel ^a   Jain, Ashokkumar ^a   Ryan, Charlotte ^a   Ornt, Daniel ^a   Zand, Martin ^a   Mantry, Parvez ^a   Lansing, Kerrie ^a   Orloff, Mark ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; STEROID; TACROLIMUS;

ADULT; AGED; ALLOGRAFT; ARTICLE; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPLAN MEIER METHOD; LIVER GRAFT; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SURVIVAL RATE; VIRUS REPLICATION;

ADULT; AGED; CADAVER; CAUSE OF DEATH; GRAFT SURVIVAL; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LIVING DONORS; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 1942504262     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000122142.00818.9E     Document Type: Article

References (26)

1. Marcos A. Right lobe living donor liver transplantation: a review. Liver Transpl 2000; 6(1): 3.
2. Williams RS, Alisa AA, Karani JB, et al. Adult-to-adult living donor liver transplant: UK experience. Eur J Gastroenterol Hepatol 2003; 15(1): 7.
3. Olzinski AT, Marcos A. Adult-to-adult living donor liver transplantation. Curr Gastroenterol Rep 2001; 3(1): 65.
4. Chen CL, Fan ST, Lee SG, et al. Living-donor liver transplantation: 12 years of experience in Asia. Transplantation 2003; 75(Suppl 3): S6.
5. Millis JM, Cronin DC, Brady LM, et al. Primary living-donor liver transplantation at the University of Chicago: technical aspects of the first 104 recipients. Ann Surg 2000; 232(1): 104.
6. Fausto N, Campbell JS. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 2003; 120(1): 117.
7. Fausto N, Webber EM. Control of liver growth. Crit Rev Eukaryot Gene Expr 1993; 3(2): 117.
8. Russo MW, Galanko JA, Beavers K, et al. Patient and graft survival after adult living donor liver transplantation in patients with chronic hepatitis C: an analysis of united network for organ sharing database. Hepatology 2003; 38(4 Suppl 1): 159a.
9. Bozorgzadeh A, Jain AB, Daller J, et al. Impact of hepatitis C viral (HCV) infection in primary cadaveric liver allograft v/s primary living liver allograft in 100 consecutive liver transplant patients. Hepatology 2003; 38(4 Suppl 1): 532a.
10. Gaglio P, Malineddy S, Levitt B, et al. Increased risk of cholestatic hepatitis C in recipients of graft from living versus cadaveric liver donors. Hepatology 2003; 38(4 Suppl 1): 160a.
11. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22(6): 696.
12. Marcos A, Fisher RA, Ham JM, et al. Right lobe living donor liver transplantation. Transplantation 1999; 68(6): 798.
13. Marcos A, Ham JM, Fisher RA, et al. Surgical management of anatomical variations of the right lobe in living donor liver transplantation. Ann Surg 2000; 231(6): 824.
14. Marcos A, Ham JM, Fisher RA, et al. Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe. Liver Transpl 2000; 6(3): 296.
15. Davis GL, Albright JE, Cook SF, et al. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003; 9(4): 331.
16. Williams R, Alisa A, Karani J, et al. Living related adult-to-adult liver transplantation: meeting the donor shortage. Antiviral Res 2001; 52(2): 217.
17. Eghtesad B, Jain AB, Fung JJ. Living donor liver transplantation: ethics and safety. Transplant Proc 2003; 35(1): 51.
18. Malago M, Testa G, Marcos A, et al. Ethical considerations and rationale of adult-to-adult living donor liver transplantation. Liver Transpl 2001; 7(10): 921.
19. Kam I. Adult-adult right hepatic lobe living donor liver transplantation for status 2a patients: too little, too late. Liver Transpl 2002; 8(4): 347.
20. Consensus conference. Treatment of hepatitis C. Gastroenterol Clin Biol 2002; 26(2): B303.
21. Heathcote EJ, Shiffman ML, Cooksley WG, et al. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med 2000; 343(23): 1673.
22. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358(9286): 958.
23. Narayanan Menon KV, Poterucha JJ, El-Amin OM, et al. Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy. Liver Transpl 2002; 8(7): 623.
24. Molmenti EP, Klintmalm GB. Hepatitis C recurrence after liver transplantation. Liver Transpl 2000; 6(4): 413.
25. Singh N, Gayowski T, Ndimbie OK, et al. Recurrent hepatitis C virus hepatitis in liver transplant recipients receiving tacrolimus: association with rejection and increased immunosuppression after transplantation. Surgery 1996; 119(4): 452.
26. Wiesner RH. Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group. Transplant Proc 1998; 30(4): 1399.